Prolonged exposure to IL-1β and IFNγ induces necrosis of L929 tumor cells via a p38MAPK/NF-κB/NO-dependent mechanism

被引:19
作者
Vercammen, E. [1 ,2 ]
Staal, J. [1 ,2 ]
Van den Broeke, A. [1 ,2 ]
Haegman, M. [1 ,2 ]
Vereecke, L. [1 ,2 ]
Schotte, P. [1 ,2 ]
Beyaert, R. [1 ,2 ]
机构
[1] Univ Ghent VIB, Dept Mol Biomed Res, Unit Mol Signal Transduct Inflammat, B-9052 Ghent, Zwijnaarde, Belgium
[2] Univ Ghent, Dept Mol Biol, B-9000 Ghent, Belgium
关键词
interleukin-1; interferon; necrosis; nitric oxide; NF-kappa B;
D O I
10.1038/onc.2008.4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interleukin-1 beta (IL-1 beta)is a cytokine that shares with tumor necrosis factor (TNF) the ability to initiate largely similar signaling pathways, leading to proinflammatory gene expression. In contrast to TNF, however, IL-1 beta is not believed to induce tumor cell death. Here we demonstrate that prolonged treatment with IL-1 beta, in combination with interferon-gamma (IFN gamma), is cytotoxic for L929 tumor cells. IL-1 beta/IFN gamma- induced cytotoxicity requires only minimal amounts of IL-1b and shows morphological features of necrosis. Although TNF induces a similar response, we could exclude a contribution of endogenous TNF production in the effect of IL-1 beta/IFN gamma. Cell death in response to IL-1 beta/IFN gamma is independent of caspases, but requires the IL-1 beta/IFN gamma- induced production of inducible nitric oxide synthase ( iNOS) and NO. Moreover, necrosis and iNOS/ NO production could be prevented by treatment of the cells with a p38 mitogen activated protein kinase ( p38MAPK) or I kappa B kinase beta inhibitor. Altogether, these findings demonstrate that prolonged exposure to IL-1 beta plus IFN gamma induces L929 tumor cell necrosis, via a p38MAPK and nuclear factor-kappa B ( NF-kappa B)- dependent signaling pathway, leading to the expression of iNOS and the production of toxic NO levels.
引用
收藏
页码:3780 / 3788
页数:9
相关论文
共 50 条
[1]  
BEYAERT R, 1993, J IMMUNOL, V151, P291
[2]   The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis in response to tumour necrosis factor [J].
Beyaert, R ;
Cuenda, A ;
VandenBerghe, W ;
Plaisance, S ;
Lee, JC ;
Haegeman, G ;
Cohen, P ;
Fiers, W .
EMBO JOURNAL, 1996, 15 (08) :1914-1923
[3]  
Beyaert R, 2002, INT REV CYTOL, V214, P225
[4]   Nitric oxide and its role in apoptosis [J].
Brüne, B ;
von Knethen, A ;
Sandau, KB .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 351 (03) :261-272
[5]   Mechanisms of pancreatic β-cell death in type 1 and type 2 diabetes -: Many differences, few similarities [J].
Cnop, M ;
Welsh, N ;
Jonas, JC ;
Jörns, A ;
Lenzen, S ;
Eizirik, DL .
DIABETES, 2005, 54 :S97-S107
[6]   SB-203580 IS A SPECIFIC INHIBITOR OF A MAP KINASE HOMOLOG WHICH IS STIMULATED BY CELLULAR STRESSES AND INTERLEUKIN-1 [J].
CUENDA, A ;
ROUSE, J ;
DOZA, YN ;
MEIER, R ;
COHEN, P ;
GALLAGHER, TF ;
YOUNG, PR ;
LEE, JC .
FEBS LETTERS, 1995, 364 (02) :229-233
[7]   Specificity and mechanism of action of some commonly used protein kinase inhibitors [J].
Davies, SP ;
Reddy, H ;
Caivano, M ;
Cohen, P .
BIOCHEMICAL JOURNAL, 2000, 351 (351) :95-105
[8]   Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury [J].
Degterev A. ;
Huang Z. ;
Boyce M. ;
Li Y. ;
Jagtap P. ;
Mizushima N. ;
Cuny G.D. ;
Mitchison T.J. ;
Moskowitz M.A. ;
Yuan J. .
Nature Chemical Biology, 2005, 1 (2) :112-119
[9]  
Dunne A, 2003, SCI STKE, V2003, pre3, DOI DOI 10.1126/STKE.2003.171.RE3
[10]   Mammalian caspases: Structure, activation, substrates, and functions during apoptosis [J].
Earnshaw, WC ;
Martins, LM ;
Kaufmann, SH .
ANNUAL REVIEW OF BIOCHEMISTRY, 1999, 68 :383-424